Gene delivery platform enabling safe, effective and redosable cures for chronic disease1-10 Employees
- B2B
- Early StageStartup in initial stages
Mediphage Bioceuticals Funding
Mediphage Bioceuticals is active in the following markets / industries: biotechnology and therapeutics. The company has secured funding across 1 rounds, totaling in an amount of $3.5M. Their most recent funding was raised on March 1, 2019.
Investors of Mediphage Bioceuticals
Viking Global Investors
Global investment firm managing capital across public equity, private equity, and credit strategies
Rounds
S
Wing Venture Capital
Rounds
S